Multicomponent phytotherapeutic approach gaining momentum: Is the “one drug to fit all” model breaking down?
Authors:
- Manzoor A. RatherManzoor A. Rather
- Bilal A. BhatBBBilal A. Bhat
- 1 December 2013
- journal article
- review article
- Published by Elsevier in Phytomedicine
- Vol. 21 (1) , 1-14
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Synergy-Directed Fractionation of Botanical Medicines: A Case Study with Goldenseal (Hydrastis canadensis)Journal of Natural Products, 2011
- Antibiotic adjuvants: multicomponent anti-infective strategiesExpert Reviews in Molecular Medicine, 2011
- Artemisinin combination therapy for vivax malariaThe Lancet Infectious Diseases, 2010
- Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatinAnti-Cancer Drugs, 2010
- Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemiaProceedings of the National Academy of Sciences, 2008
- Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and TrialsCell, 2007
- Revisiting the ancient concept of botanical therapeuticsNature Chemical Biology, 2007
- Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in miceCarcinogenesis, 2007
- Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cellsCancer Chemotherapy and Pharmacology, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005